Structure Based Design of 11&bgr;-HSD1 Inhibitors

E-ISSN： 1873-4316|11|7|779-791

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.11, Iss.7, 2010-11, pp. : 779-791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

Development of 11&bgr; -HSD1 Inhibitors for the Treatment of Type 2 Diabetes

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 702-710

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors

Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-03 ,pp. : 642-649

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand-Based Drug Design to Propose Novel -Glucosidase Inhibitors

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite